UNIVERSIDAD COMPLUTENSE DE MADRID - Biblioteca de la ...

human tumor cell lines lacking class I expression.
Proc Natl Acad Sci USA 89: 2488-2492, 1992.
Bodmer JG, Marsh SGE, Albert E, Bodmer WF, Bontrop
RE, Charron D, Dupont B, Erlich HA, Mach B,
Mayr WR, Parham P, Sasazuki T, Schreuder
GMY, Strominger JL, Svejgaard A, y Terasaki PI.
Nomenclature for factors of the HLA system,
1995. Tissue Antigens 46: 1-18, 1995.
Bodmer JG, Marsh S, Albert E, Bodmer W, Bontrop R,
Charron D, Dupont B, Erlich H, Fauchet R, Mach
B, Mayr W, Parham P, Sasazuki T, Schreuder Th,
Strominger J, Svejgaard A, y Terasaki P.
Nomenclature for factors of the HLA system,
1996. En: Genetic diversity of HLA Functional
and Medical implications. Charron D (ed). Vol 2.
EDK, Paris, pp 505-532, 1997a.
Bodmer JG, Cambon-Thomsen J, Hors J, Piazza A, y
Sánchez-Mazas A. Anthropology report
introduction. En: Genetic diversity of HLA
Functional and Medical implications. Charron D
(ed). Vol 2. EDK, Paris, pp 269-284, 1997b
Bodmer WF, y Cavalli-Sforza LL. Genetics, Evolution,
and Man. San Francisco: WH Freeman, p 573,
1976.
Bonné-Tamir B, Bodmer JG, Bodmer W, Pickbourne P, y
Brautbar C. HLA polymorphism in Israel. An
overall comparative analysis. Tissue Antigens 11:
235-250, 1978.
Borrego F, Ulbrecht M, Weiss E, Coligan JE, y Brooks
AG. Recognition of human histocompatibility
leukocyte antigen HLA-E complexed with HLA
class I signal sequence derived peptides by
CD94/NKG2 confers protection from Natural
Killer cell mediated lysis. J Exp Med 187: 813-
818, 1998.
Braud VM, Jones EY, y McMichael AJ. The human major
histocompatibility complex class Ib molecule
HLA-E binds signal sequence-derived peptides
with primary anchor residues at positions 2 and
9. Eur J Immunol 27: 1164-1169, 1997a.
Braud VM, Allan DSJ, Wilson D, y McMichael AJ. TAP
and tapasin-dependent HLA-E surface expression
correlated with the binding of an MHC class I
leader peptide. Curr Biol 8: 1-10, 1997b.
Braud VM, Allan DSJ, O'Callaghan CA, Söderström K,
D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell
JI, Phillips JH, Lanier LL, y McMichael AJ.
HLA-E binds to natural killer cells receptors
CD94/NKG2A, B and C. Nature 391: 795-799,
1998.
Brautbar C, Friedmann A, Battat S, Tambur R, Cambon-
Thomsen A, Ohayon E, Tongio M, Dupont E, y
Essakali-Gharbi M. HLA in Israeli Jews,
Moroccans and Algerians. En: HLA 1991. Tsuji
K, Aizawa M, Sasazuki T (eds). Vol I, Oxford:
Eduardo Gómez Casado
Bibliografía 141
Oxford University Press, Oxford, pp 656-658,
1992.
Brega A, Scacchi R, Cuccia M, Kirdar B, Peloso G, y
Corbo RM. Study of 15 protein polymorphisms in
a sample of the Turkish population. Hum biol 70:
715-728, 1998.
Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG,
Strominger JL, y Wiley DC. The threedimensional
structure of the human class II
histocompatibility antigen HLA-DR1. Nature 364:
33-39, 1993.
Burillo-Mozola F. Los Celtíberos. Barcelona: Ed. Crítica,
Grijalbo-Mondadori, 1998.
Burmeister WP, Gastinel LN, Simister NE, Blum ML, y
Bjorkman PJ. The 2.2A resolution crystal
structure of the MHC-related neonatal Fc
receptor. Nature 372: 336-343, 1994.
C
Calabi F, y Milstein C. A novel family of human major
histocompatibility complex-related genes not
mapping to Cr.6. Nature 323: 540-543, 1986.
Cammarota G, Sheirie A, Takacs B, Doran DM, Knorr R,
Bannwarth W, Guardiola J, y Sinigaglia F.
Identification of a CD4 binding site on the β2
domain of HLA-DR molecules. Nature 356: 799-
801, 1992.
Campbell RD, y Trowsdale J. A map of the human major
histocompatibility complex. Immunol Today 19,
1997.
Carreno BM, Solheim JC, Harris M, Stroynowski I,
Connolly JM, y Hansen TH. TAP associated with
a unique class I conformation, whereas calnexin
associated with multiple class I form in mouse
and men. J Immunol 155: 4726-4733, 1995.
Ceppellini R, Curtoni ES, Mattiuz PL, Miggiano V,
Scudeller G, y Serra A. Genetics of leukocyte
antigens. A family study of segregation and
linkage. En: Histocompatibility Testing 1967.
Curtoni ES, Mattiuz PL, Tosi RM (eds).
Munksgaard, Copenhagen, 149-187, 1967.
Cereb N, Kong Y, Lee S, Maye P, y Yang SY. Nucleotide
sequences of MHC class I introns 1, 2 and 3 in
humans and intron 2 in nonhuman primates.
Tissue Antigens 47: 498-511, 1996.
Chang CH, Fontes JD Peterlin BM, y Flavell RA. Class II
transactivator (CIITA) is sufficient for the
inducible expression of major histocompatibility
complex class II genes. J Exp Med 180: 1367-
1374, 1994.